pentobarbital will improve the stage or influence of clopidogrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will decrease the level or outcome of atorvastatin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will minimize the level or result of ritonavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will decrease the extent or effect of rolapitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Extended-expression coadministration of robust CYP3A4 inducers with rolapitant could drastically reduce rolapitant efficacy.
pentobarbital will decrease the level or outcome of diazepam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lower the extent or impact of darunavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
Warning when discontinuing CYP3A4 inducers which can be coadministered with benzhydrocodone (prodrug of hydrocodone); plasma concentrations of hydrocodone may perhaps boost and may lead to possibly fatal respiratory melancholy.
pentobarbital and olopatadine intranasal both maximize sedation. Stay away from or Use Alternate Drug. Coadministration increases threat of CNS despair, which can lead to additive impairment of psychomotor performance and bring about daytime impairment.
pentobarbital will lessen the level or outcome of abiraterone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will lessen the level or effect of aprepitant website by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lower the level or influence of atogepant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Suggested atogepant dosage with concomitant use of robust or reasonable CYP3A4 inducers is 30 mg or 60 mg qDay.
Observe Carefully (two)pentobarbital will decrease the level or effect of suvorexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Powerful CYP3A4 inducers may well decrease suvorexant efficacy; if greater suvorexant dose required, tend not to exceed 20 mg/working day
Check Intently (one)pentobarbital will minimize the extent or influence of tadalafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the level or effect of atazanavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown.